Literature DB >> 3288451

Treatment of desmoid tumors in Gardner's syndrome. Report of a case.

H Itoh1, S Ikeda, Y Oohata, M Iida, T Inoue, H Onitsuka.   

Abstract

Aggressive desmoid tumors present difficult problems among patients with Gardner's syndrome. Recently, attention has been directed toward metabolic or hormonal manipulation of these tumors. A 21-year-old woman with Gardner's syndrome was admitted because of recurrent abdominal wall tumors. She was treated with nonsteroidal anti-inflammatory drugs, tamoxifen, and ascorbate for seven months. During this therapy, CT scan showed a gradual increase in size of the tumors. Subsequent resection of the abdominal tumors and the colon was performed. Although these three types of drugs were administered to prevent postoperative recurrence, an abdominal wall desmoid tumor that invaded the mesentery developed within nine months. The known treatments, that is, chemotherapy, irradiation, and surgical resection are discussed in view of this experience.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3288451     DOI: 10.1007/bf02552617

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  7 in total

Review 1.  Mesenteric desmoid tumours in Gardner's syndrome--review of medical treatments.

Authors:  B A Eagel; P Zentler-Munro; I E Smith
Journal:  Postgrad Med J       Date:  1989-07       Impact factor: 2.401

Review 2.  Is there a role for oral or intravenous ascorbate (vitamin C) in treating patients with cancer? A systematic review.

Authors:  Carmel Jacobs; Brian Hutton; Terry Ng; Risa Shorr; Mark Clemons
Journal:  Oncologist       Date:  2015-01-19

Review 3.  Nonsteroidal anti-inflammatory drugs for the prevention of colon cancer.

Authors:  D Turner; H J Berkel
Journal:  CMAJ       Date:  1993-09-01       Impact factor: 8.262

4.  Identification of somatic APC mutations in recurrent desmoid tumors in a patient with familial adenomatous polyposis to determine actual recurrence of the original tumor or de novo occurrence.

Authors:  Takeo Iwama; Kouki Kuwabara; Mineko Ushiama; Teruhiko Yoshida; Kokichi Sugano; Hideyuki Ishida
Journal:  Fam Cancer       Date:  2008-08-15       Impact factor: 2.375

Review 5.  Nonsteroidal antiinflammatory agents in chemoprevention of colorectal cancer. At what cost?

Authors:  M A Trujillo; H S Garewal; R E Sampliner
Journal:  Dig Dis Sci       Date:  1994-10       Impact factor: 3.199

6.  The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment.

Authors:  T Iwama; Y Mishima; J Utsunomiya
Journal:  Ann Surg       Date:  1993-02       Impact factor: 12.969

7.  Different phenotypes of gastric fundic gland polyposis and cancer in patients with familial adenomatous polyposis depending on Helicobacter pylori infection.

Authors:  Yasuhiro Mitsui; Ayaka Miyoshi; Koichi Okamoto; Naoki Muguruma; Jinsei Miyoshi; Kumiko Tanaka; Shinji Kitamura; Hiroshi Miyamoto; Yasushi Sato; Yoshimi Bando; Joji Shunto; Hidetaka Eguchi; Yasushi Okazaki; Hideyuki Ishida; Tetsuji Takayama
Journal:  Gastric Cancer       Date:  2019-09-16       Impact factor: 7.370

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.